0001654954-17-000958.txt : 20170210 0001654954-17-000958.hdr.sgml : 20170210 20170210172753 ACCESSION NUMBER: 0001654954-17-000958 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20170210 DATE AS OF CHANGE: 20170210 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Medovex Corp. CENTRAL INDEX KEY: 0001591165 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-88823 FILM NUMBER: 17594808 BUSINESS ADDRESS: STREET 1: 3729 HARDEE AVENUE CITY: ATLANTA STATE: GA ZIP: 30341 BUSINESS PHONE: (404) 393-6989 MAIL ADDRESS: STREET 1: 3729 HARDEE AVENUE CITY: ATLANTA STATE: GA ZIP: 30341 FORMER COMPANY: FORMER CONFORMED NAME: SpineZ DATE OF NAME CHANGE: 20131105 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Honig Renee Hersey CENTRAL INDEX KEY: 0001640877 FILING VALUES: FORM TYPE: SC 13G/A MAIL ADDRESS: STREET 1: 555 S. FEDERAL HIGHWAY #450 CITY: BOCA RATON STATE: FL ZIP: 33432 SC 13G/A 1 rhonig13ga_mdvx.htm AMENDMENT NO. 1 TO SCHEDULE 13G SEC Connect
 

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
 
 Amendment No. 1
To
SCHEDULE 13G
(Rule 13d-102)
 
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULE 13d-1(b) (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO
RULE 13d-2(b)
 
 
MEDOVEX CORP.
(Name of Issuer)
 
COMMON STOCK, PAR VALUE $0.001 PER SHARE
(Title of Class of Securities)
 
58504H101
(CUSIP Number)
 
December 31, 2016
(Date of Event Which Requires Filing of This Statement)
 
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
 
[   ] Rule 13d-1(b)
[ x] Rule 13d-1(c)
[   ] Rule 13d-1(d)
 
 

 
 
 
 
CUSIP No. 58504H101
 
 
 
1
 
NAME OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
 
Renee Honig
 
2
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*                                             (a) ☐
                                                                                                                                                              (b) ☐
 
3
 
SEC USE ONLY
 
 
4
 
CITIZENSHIP OR PLACE OF ORGANIZATION
 
United States
 
 
NUMBER
 
OF SHARES
 
5
 
SOLE VOTING POWER
 
325,000
 
BENEFICIALLY
 
OWNED BY
 
6
 
SHARED VOTING POWER
 
819,389(1)
 
EACH
 
REPORTING
 
7
 
SOLE DISPOSITIVE POWER
 
325,000
 
PERSON WITH
 
8
 
SHARED DISPOSITIVE POWER
 
 819,389(1)
 
9
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
 
1,144,389(1)
 
10
 
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)
 
11
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
 
7.55% (Based on 15,032,107 shares outstanding as of November 16, 2016)
 
12
 
TYPE OF REPORTING PERSON*
 
IN
 
(1)
Includes (i) 230,200 shares of common stock held by Renee Honig’s spouse, Barry Honig, (ii) 95,952 shares of common stock underlying warrants issued as part of a unit held by Barry Honig, (iii) 453,101 shares of common stock held by GRQ Consultants, Inc. Roth 401K FBO Barry Honig (“Roth 401K”), for which Barry Honig is trustee and over which securities he holds voting and dispositive power, (iv) 10,586 shares of common stock held by Marlin Capital Investments, LLC (“Marlin”), for which Barry Honig is the managing member and over which securities he holds voting and dispositive power, and (iv) 29,550 shares of common stock underlying warrants issued as part of a unit held by GRQ Consultants, Inc. 401K (“401K”), for which Barry Honig is trustee and over which securities he holds voting and dispositive power. Excludes (i) 43,478 shares of common stock underlying warrants held by Barry Honig, (ii) 95,000 shares of common stock underlying warrants held by 401K, (iii) 68,508 shares of common stock underlying warrants held by Roth 401K, and (iv) 75,000 shares of common stock underlying warrants held by Barry & Renee Honig Charitable Foundation (the “Foundation”), for which Barry Honig is trustee and over which securities he holds voting and dispositive power. All of these warrants contain a 4.99% beneficial ownership blocker, and as such the Reporting Person’s beneficial ownership has been limited accordingly.
 
 
 
 
 
Item (a).
Name of Issuer:
 
Medovex Corp., a Nevada corporation (“Issuer”)
 
Item 1(b).
Address of Issuer's Principal Executive Offices:
 
3279 Hardee Avenue
Atlanta, Georgia 30341
 
Item 2(a).
Name of Person Filing.
 
The statement is filed on behalf of Renee Honig (the “Reporting Person”).
 
Item 2(b).
Address of Principal Business Office or, if None, Residence.
 
555 South Federal Highway #450, Boca Raton, FL 33432
 
Item 2(c).
Citizenship.
 
Renee Honig is a citizen of the United States.
 
Item 2(d).
Title of Class of Securities.
 
Common Stock, par value $0.001.
 
Item 2(e).
CUSIP Number.
 
58504H101
 
Item 3.
Type of Person.
 
Not applicable.
 
Item 4.
Ownership.
              
(a) Amount beneficially owned:  1,144,389(1)
(b) Percent of class:  7.55% (Based on 15,032,107 shares outstanding as of November 16, 2016)
(c) Number of shares as to which the person has:
 
(i) Sole power to vote or to direct the vote: 325,000
(ii) Shared power to vote or to direct the vote:  819,389 (1) 
(iii) Sole power to dispose or to direct the disposition of: 325,000
(iv) Shared power to dispose or to direct the disposition of:  819,389(1)
____________________________
(1)
Includes (i) 230,200 shares of common stock held by Renee Honig’s spouse, Barry Honig, (ii) 95,952 shares of common stock underlying warrants issued as part of a unit held by Barry Honig, (iii) 453,101 shares of common stock held by Roth 401K, (iv) 10,586 shares of common stock held by Marlin, and (iv) 29,550 shares of common stock underlying warrants issued as part of a unit held by 401K. Excludes (i) 43,478 shares of common stock underlying warrants held by Barry Honig, (ii) 95,000 shares of common stock underlying warrants held by 401K, (iii) 68,508 shares of common stock underlying warrants held by Roth 401K, and (iv) 75,000 shares of common stock underlying warrants held by the Foundation. All of these warrants contain a 4.99% beneficial ownership blocker, and as such the Reporting Person’s beneficial ownership has been limited accordingly.
 
 
 
 
Item 5.
Ownership of Five Percent or Less of a Class.
 
Not applicable.
 
Item 6.
Ownership of More than Five Percent on Behalf of Another Person.
 
Not applicable.
 
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported by the Parent Holding Company.
 
Not applicable.
 
Item 8.
Identification and Classification of Members of the Group.
 
Not applicable.
 
Item 9.
Notice of Dissolution of Group.
 
Not applicable.
 
Item 10.
Certifications.
 
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
 
 
 
 
SIGNATURE
 
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
 
Date: February 10, 2017
By: 
/s/ Renee Honig
 
 
 
Renee Honig